J07AH09
meningococcus B, multicomponent vaccine
Наименование на групата: WHO Collaborating Centre for Drug Statistics Methodology
Лекарствени продукти в тази категория
2 продукта в тази категория и подгрупите ѝ.
| Търговско име | Концентрация |
|---|---|
| Bexsero | --¹ One dose (0.5 ml) contains: Recombinant Neisseria meningitidis group B NHBA fusion protein ¹, ², ³ 50 micrograms Recombinant Neisseria meningitidis group B NadA protein ¹, ², ³ 50 micrograms Recombinant Neisseria meningitidis group B fHbp fusion protein ¹, ², ³ 50 micrograms Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4² 25 micrograms ¹ produced in E. coli cells by recombinant DNA technology ² adsorbed on aluminium hydroxide (0.5 mg Al³+) ³ NHBA (Neisseria Heparin Binding Antigen), NadA (Neisserial adhesin A), fHbp (factor H binding protein) |
| Trumenba | --¹ 1 dose (0.5 ml) contains: Neisseria meningitidis serogroup B fHbp subfamily A¹,²,³ 60 micrograms Neisseria meningitidis serogroup B fHbp subfamily B¹,²,³ 60 micrograms ¹ Recombinant lipidated fHbp (factor H binding protein) ² Produced in Escherichia coli cells by recombinant DNA technology ³ Adsorbed on aluminium phosphate (0.25 milligram aluminium per dose) |